Intellectual Property India Publishes Patent Application for 'Compounds With A Glutarimide-Isoindolinone Scaffold' Filed by Gluetacs Therapeutics (SHANGHAI) Co. Ltd.

MUMBAI, India, March 14 -- Intellectual Property India has published a patent application (202617016042 A) filed by Gluetacs Therapeutics (SHANGHAI) Co. Ltd., Shanghai, on Feb. 13, for 'compounds with a glutarimide-isoindolinone scaffold.'

Inventor(s) include Yang, Xiaobao; Sun, Renhong; Ren, Chaowei; Zhao, Baoyin; Zhou, Yuedong; Yang, Sen; Deng, Meigui; and Ren, Yinbo.

The application for the patent was published on March 13, under issue no. 11/2026.

According to the abstract released by the Intellectual Property India: "Disclosed are a glutarimide isoindolinone skeleton-based compound represented by formula (I) or a salt, enantiomer, stereoisomer, solvate, isotope-enriched analogue, prodrug or polymorphic substance thereof, and a use thereof in the treatment and prevention of cereblon protein-related diseases or disorders including tumors or cancers."

The patent application was internationally filed on July 15, 2024, under International application No.PCT/CN2024/105487.

Disclaimer: Curated by HT Syndication.